
ãããã¯å¹éªã§ãã«ãã§ãªã¬é£²ã¿ããã«çä¹³ãè²·ãã«èµ°ãïœæã®äžæ¯ã¯å¿ é ã®ãä»äºã¹ã€ããã
ããã«ã¡ã¯ãå»çã©ã€ã¿ãŒã®äžžå²¡ã¿ã©ãã§ãã
ãããã¯å€§ã®ã«ãã§ãªã¬å¥œãã
æã«å·èµåº«ãéããŠãããŸã£ãïŒçä¹³ãåããŠãïŒããšæ°ã¥ããšãããšãå¹éªã§ãããŠã³ããããããšçŸœç¹ã£ãŠè¿æã®ããŒãœã³ã«èµ°ããŸããïŒãšãã£ãŠããåŸæ©2åã®è·é¢ã§ããâŠïŒ
ãã³ãåµãªãã仿¥ã¯ãŸããããããšãªããŸããåšå® ã¯ãŒã¯åã®è²Žéãªååäžã«ããããè²·ãç©ãžè¡ãã®ã¯ãå°ããã£ãããªãæ°ãããŠããŸãããã§ããåã«é¢åãããããããšããçç±ãããã®ã§ããïŒç¬ïŒ
ãšããããçä¹³ã ãã¯å¥ãé¢åããããã«ãã§ãªã¬ã飲ã¿ããïŒãã倧ããäžåããŸãã
ãããã«ãšã£ãŠã«ãã§ãªã¬ã¯ãä»äºã®ã¹ã€ãããå ¥ããããã®å°ããªååŒã®ãããªååšãªã®ãããããŸããã
ããæããµãšçåã«æããŸãããã©ãããŠãããŸã§ã«ãã§ãªã¬ã飲ã¿ãããªãã®ã ããïŒãšã2æ¯çšåºŠãªã®ã§ãã«ãã§ã€ã³ã®é¢è±çç¶ãšããã»ã©ã§ããããŸããã
ããããããšãçä¹³ã®æåã«äœãçç±ãããã®ã§ã¯ïŒãšæããè±èªè«æïŒPubMedïŒã§èª¿ã¹ãŠã¿ãããšã«ããŸããã
è¿å¹Žã®åºç€ç ç©¶ã§ã¯ãçä¹³ç±æ¥ã®ããããã®äžçš®ã§ããïŒã«ãœã¢ã«ãã£ã³-10ïŒãšããç©è³ªããç¥çµäŒéãçäœãªãºã ã«é¢ããå¯èœæ§ã瀺åãããŠããŸããïŒãã ãããã®ç ç©¶ã¯çްèã¬ãã«ã§è¡ããããã®ã§ãæ¥åžžç掻ãžã®çŽæ¥çãªåœ±é¿ã確èªãããããã§ã¯ãããŸããïŒ
ããã§ããèªåã®æã®ååŒã«ç§åŠçãªèæ¯ãããã®ãããããªããšæããšããªãã ãå°ãé¢çœãæããŸããã
å¹éªã®ãªãããŒãœã³ãžåãã£ãã®ã¯ãåãªãå奜ã ãã§ãªããæ°æã¡ãåãæ¿ããã¹ã€ãããæ±ããŠããããâŠããèãããšçŽåŸã§ãã
æè¿ã§ã¯ãé»åã®ãã«ã¯ãã©ãŒããŒã§æ³¡ç«ãŠãŠããµããµãã®ã«ãã§ãªã¬ã楜ããã§ããŸãã
çè·åž«ãšããŠãæ®æ®µã¯ãšããã³ã¹ãéèŠããå»çèšäºãå·çããŠããŸãã
æ¥åžžã®å°ããªçåãè«æã§ã®ãããŠã¿ãã®ã¯ããªããªãã¯ã¯ã¯ã¯ããæéã§ãã
æ¥åžžã®éåæãè±èªè«æã§æ€èšŒããã·ãªãŒãºã
次åã¯ãæãå®¶ã®ç«ã®è¡åãæ€èšŒããŠã¿ããããªãšæã£ãŠãŸãã
ãåèæç®ã
Fukunaga, M., Watanabe, S., Orihara, K., & Yamamoto, N. (2025). Casomorphine-10 (CM-10) Peptide Orchestrates Circadian and Neurodevelopmental Gene Clusters via ÎŽ-Opioid Receptor Signaling: Insights from Transcriptome Analysis with ÎŽ-Opioid Receptor-Expressing HEK293 Cells. Life, 15(10), 1636.
https://pubmed.ncbi.nlm.nih.gov/41157308/
å»çã»ãã«ã¹ã±ã¢åéã®å·çå®çžŸã¯ãããŒããã©ãªãªããã芧ããã ããŸãã